2020
DOI: 10.1038/s41419-020-03263-6
|View full text |Cite
|
Sign up to set email alerts
|

LncRNA kcnq1ot1 promotes lipid accumulation and accelerates atherosclerosis via functioning as a ceRNA through the miR-452-3p/HDAC3/ABCA1 axis

Abstract: Kcnq1 overlapping transcript 1 (kcnq1ot1), an imprinted antisense lncRNA in the kcnq1 locus, acts as a potential contributor to cardiovascular disease, but its role in atherosclerosis remains unknown. The aim of this study was to explore the effects of kcnq1ot1 on atherogenesis and the underlying mechanism. Our results showed that kcnq1ot1 expression was significantly increased in mouse aorta with atherosclerosis and lipid-loaded macrophages. Lentivirus-mediated kcnq1ot1 overexpression markedly increased ather… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

1
50
0

Year Published

2021
2021
2023
2023

Publication Types

Select...
10

Relationship

1
9

Authors

Journals

citations
Cited by 70 publications
(51 citation statements)
references
References 48 publications
1
50
0
Order By: Relevance
“…Our results showed that CTRP12 polarized macrophages towards an M2 phenotype and attenuated vascular inflammation through the miR-155-5p/LXRα pathway, thereby providing another important mechanism for its antiatherogenic action. A growing body of evidence has indicated that lncRNAs are pivotal regulators of atherogenesis 62 , 63 . More recently, Wang et al reported that the expression levels of CTBP1-AS2, a lncRNA, were significantly decreased in the serum of patients with atherosclerosis, and its overexpression inhibits proliferation and promotes autophagy in human aortic smooth muscle cells challenged with ox-LDL 64 .…”
Section: Discussionmentioning
confidence: 99%
“…Our results showed that CTRP12 polarized macrophages towards an M2 phenotype and attenuated vascular inflammation through the miR-155-5p/LXRα pathway, thereby providing another important mechanism for its antiatherogenic action. A growing body of evidence has indicated that lncRNAs are pivotal regulators of atherogenesis 62 , 63 . More recently, Wang et al reported that the expression levels of CTBP1-AS2, a lncRNA, were significantly decreased in the serum of patients with atherosclerosis, and its overexpression inhibits proliferation and promotes autophagy in human aortic smooth muscle cells challenged with ox-LDL 64 .…”
Section: Discussionmentioning
confidence: 99%
“…Since many studies have confirmed lncRNAs’ regulatory roles in lipid homeostasis, some researchers think they may take part in the development of atherosclerosis. LncRNA KCNQ1OT1 could inhibit cholesterol efflux and promote lipid accumulation in macrophages via the miR-452-3p/HDAC3/ABCA1 pathway, and, thus, contribute to the development of atherosclerosis ( Yu et al, 2020 ). A key node in atherosclerosis is when macrophages uptake lipoproteins and form foam cells ( Tabas and Bornfeldt, 2020 ).…”
Section: The Potential Of Lncrnas As Therapeutic Targets Of Related Diseases Induced By Adipocyte Dysfunctionmentioning
confidence: 99%
“…It has been found that lncRNA APF targets the regulation of miR-188-3p, thereby affecting the expression of ATG7 in autophagy, which can effectively reduce the area of myocardial infarction, prevent HF, and prolong survival time (13). LncRNA kcnq1ot1 was demonstrated to increase HDAC3 expression by competitively binding to miR-452-3p, followed by the inhibition of ABCA1 and cholesterol efflflux, promoted macrophage lipid accumulation and accelerated the development of atherosclerosis (14). The above findings highlighted the importance of ceRNA network, a global view of lncRNAmediated ceRNA network may help researchers comprehensively understand the pathophysiological process of cardiovascular diseases.…”
Section: Introductionmentioning
confidence: 99%